Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18F]-2-fluoro-2-deoxy-D-glucose and PET.

Cerebral PET with [18F]-2-fluoro-2-deoxy-D-glucose has been performed in four patients with neurofibromatosis type 1 (NF1) to assess the relation between cerebral metabolic activity, MRI, and the presence of neurological symptoms, including seizures, as well as mental and language retardation. Wides...

詳細記述

保存先:
書誌詳細
主要な著者: Balestri, P, Lucignani, G, Fois, A, Magliani, L, Calistri, L, Grana, C, Di Bartolo, R M, Perani, D, Fazio, F
フォーマット: Artigo
言語:Inglês
出版事項: 1994
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1073228/
https://ncbi.nlm.nih.gov/pubmed/7798976
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料